Warm Springs Advisors Inc. Grows Stock Holdings in Intuitive Surgical, Inc. $ISRG

Warm Springs Advisors Inc. boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 231.5% during the third quarter, Holdings Channel reports. The firm owned 7,160 shares of the medical equipment provider’s stock after purchasing an additional 5,000 shares during the quarter. Intuitive Surgical comprises about 2.4% of Warm Springs Advisors Inc.’s holdings, making the stock its 16th biggest position. Warm Springs Advisors Inc.’s holdings in Intuitive Surgical were worth $3,202,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also added to or reduced their stakes in ISRG. Norges Bank bought a new position in shares of Intuitive Surgical during the 2nd quarter valued at $2,569,260,000. Rakuten Investment Management Inc. purchased a new stake in Intuitive Surgical during the third quarter valued at $388,436,000. Vanguard Group Inc. lifted its holdings in Intuitive Surgical by 2.1% in the second quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock valued at $18,115,025,000 after acquiring an additional 670,302 shares during the period. Canada Pension Plan Investment Board lifted its holdings in Intuitive Surgical by 27.1% in the second quarter. Canada Pension Plan Investment Board now owns 1,089,293 shares of the medical equipment provider’s stock valued at $591,933,000 after acquiring an additional 231,980 shares during the period. Finally, Winslow Capital Management LLC boosted its position in Intuitive Surgical by 20.2% in the second quarter. Winslow Capital Management LLC now owns 1,342,473 shares of the medical equipment provider’s stock worth $729,513,000 after purchasing an additional 225,545 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. Raymond James Financial upped their price target on shares of Intuitive Surgical from $603.00 to $615.00 and gave the company an “outperform” rating in a research report on Friday, January 23rd. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Intuitive Surgical in a report on Monday, December 29th. Citigroup reiterated a “neutral” rating and issued a $590.00 price target (down from $635.00) on shares of Intuitive Surgical in a research report on Friday, January 23rd. Evercore dropped their price target on shares of Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating on the stock in a research note on Friday, January 23rd. Finally, BTIG Research restated a “buy” rating and issued a $616.00 price objective on shares of Intuitive Surgical in a research note on Friday, January 23rd. Two research analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $615.86.

Insiders Place Their Bets

In other news, VP Fredrik Widman sold 133 shares of the company’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $65,829.68. Following the completion of the transaction, the vice president owned 660 shares of the company’s stock, valued at $326,673.60. This represents a 16.77% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Myriam Curet sold 421 shares of the stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $208,378.16. Following the sale, the executive vice president owned 409 shares of the company’s stock, valued at $202,438.64. This represents a 50.72% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 56,189 shares of company stock valued at $30,785,441 over the last three months. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Price Performance

ISRG opened at $506.88 on Friday. The company has a 50 day simple moving average of $531.21 and a two-hundred day simple moving average of $511.26. The firm has a market cap of $180.01 billion, a P/E ratio of 64.24, a PEG ratio of 3.90 and a beta of 1.65. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. Intuitive Surgical’s revenue for the quarter was up 18.8% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.21 EPS. Equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.